BiotechTube
Ulisse BioMed

Ulisse BioMed

Trieste, Italy· Est.
ulissebiomed.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Ulisse BioMed has recently undergone a strategic transformation, rebranding to Helyx Industries to reflect its evolved business structure. The company consolidates its expertise into three divisions (Hyris, Vytro, Mytho) aimed at delivering end-to-end molecular biology solutions, spanning diagnostics, sequencing, and a proprietary technology platform. This move signals a shift from a pure-play RNA therapeutics/diagnostics developer to a broader integrated solutions provider in the life sciences tools and diagnostics space. The new corporate identity and website (helyx.bio) mark the beginning of this next phase.

Genetics & Genomics

Technology Platform

Integrated molecular biology platform spanning three divisions: Hyris (PCR solutions), Vytro (next-generation sequencing solutions), and Mytho (a unique proprietary platform).

Funding History

1
SeedUndisclosed

Opportunities

The rebranding to Helyx Industries allows the company to address the large and growing market for integrated molecular biology solutions, from diagnostics to sequencing.
Its multi-division structure creates cross-selling opportunities and positions it to serve the trend towards decentralized, streamlined workflows in both clinical and research settings.

Risk Factors

Execution risk is high due to the recent major strategic pivot and the challenge of integrating three distinct divisions.
The company faces intense competition from large, established players in the molecular diagnostics and NGS markets.
Technological and financing risks also persist, particularly for the development of its unproven proprietary platform.

Competitive Landscape

Helyx Industries competes in the crowded life sciences tools and diagnostics sector, facing giants like Roche, Thermo Fisher Scientific, Illumina, and Qiagen. Its strategy is to differentiate through an integrated, multi-division model offering end-to-end solutions, rather than competing on a single product. Success will depend on the uniqueness of its Mytho platform and its ability to offer superior bundled value.

More companies in Diagnostics & Precision Medicine →More companies in Italy →